1. Home
  2. LPX vs SHC Comparison

LPX vs SHC Comparison

Compare LPX & SHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Louisiana-Pacific Corporation

LPX

Louisiana-Pacific Corporation

HOLD

Current Price

$76.55

Market Cap

4.9B

ML Signal

HOLD

Logo Sotera Health Company

SHC

Sotera Health Company

HOLD

Current Price

$15.78

Market Cap

4.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LPX
SHC
Founded
1973
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Forest Products
Medical Specialities
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.9B
4.4B
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
LPX
SHC
Price
$76.55
$15.78
Analyst Decision
Strong Buy
Buy
Analyst Count
7
7
Target Price
$105.29
$20.33
AVG Volume (30 Days)
1.0M
2.6M
Earning Date
05-06-2026
05-05-2026
Dividend Yield
1.59%
N/A
EPS Growth
N/A
68.75
EPS
2.08
0.27
Revenue
$2,708,000,000.00
$1,163,617,000.00
Revenue This Year
N/A
$7.51
Revenue Next Year
$11.23
$6.00
P/E Ratio
$36.26
$57.50
Revenue Growth
N/A
5.74
52 Week Low
$68.87
$10.68
52 Week High
$102.86
$19.85

Technical Indicators

Market Signals
Indicator
LPX
SHC
Relative Strength Index (RSI) 53.46 56.35
Support Level $74.00 $15.19
Resistance Level $76.79 $16.55
Average True Range (ATR) 2.91 0.38
MACD 0.56 0.03
Stochastic Oscillator 84.96 52.47

Price Performance

Historical Comparison
LPX
SHC

About LPX Louisiana-Pacific Corporation

Louisiana-Pacific Corp is an oriented strand board producer and also offers engineered wood siding used in home construction and repair and remodel projects. The Siding business of the company serves different markets with a broad product portfolio of engineered wood siding, trim, soffit, and fascia. The Company operates through three operating segments: Siding, OSB, and LP South America (LPSA). The company generates majority of its revenue from siding segment.

About SHC Sotera Health Company

Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical, and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three reportable segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment, which generates maximum revenue, provides outsourced terminal sterilization and irradiation services for medical devices, pharmaceuticals, food safety, and other application markets using three core technologies: gamma irradiation, EO processing, and E-beam irradiation. Geographically, the company generates maximum revenue from the United States, followed by Canada, Europe, and other regions.

Share on Social Networks: